Related Experiment Video
Updated: Jul 11, 2026

19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Infant autonomic function is altered by maternal smoking during pregnancy
C A Browne1, P B Colditz, K R Dunster
1Perinatal Research Centre, The University of Queensland, Royal Women's Hospital, Brisbane, QLD 4029, Australia. brownec@health.qld.gov.au
Early Human Development
|September 21, 2000
Summary
Maternal smoking alters infant blood pressure responses during head-up tilt tests. This suggests impaired autonomic control in infants exposed to smoking, potentially impacting sudden infant death syndrome (SIDS) risk.
Area of Science:
- Neonatal physiology
- Autonomic nervous system function
- Cardiovascular regulation
Background:
- Sudden infant death syndrome (SIDS) is linked to smoking during pregnancy.
- Autonomic control mechanisms may be subtly altered in infants of smokers.
- Head-up tilt tests and heart rate variability analysis assess autonomic function.
Purpose of the Study:
- To investigate the impact of maternal smoking on infant cardiovascular responses to head-up tilt.
- To compare autonomic responses between infants of smokers and non-smokers at different ages.
Main Methods:
- Passive 70-degree head-up tilt test performed on infants.
- Blood pressure and heart rate variability were monitored.
- Comparison between infants of smokers and non-smokers at 2-3 days and 3 months of age.
Main Results:
- No significant differences in heart rate variability indices were found between groups.
- At 2-3 days, infants of smokers showed a significant decrease in systolic blood pressure during tilt (P<0.01).
- At 3 months, systolic blood pressure remained unchanged in infants of smokers but increased in controls (P<0.05).
Conclusions:
- Maternal smoking significantly alters infant blood pressure regulation during head-up tilt.
- These findings suggest impaired autonomic cardiovascular control in infants exposed to maternal smoking.
- The observed alterations may contribute to the increased risk of SIDS in infants of smokers.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...

